Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_assertion type Assertion NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_head.
- NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_assertion description "[Other GDEPT paradigms, such as ganciclovir (GCV) and Herpes Simplex thymidine kinase (HSV-tk), dinitrobenzamide (DNB) mustard or aziridinyl analogs and the E. coli nitroreductase (NTR), CMDA or ZP2767P with Pseudomonas aeruginosa carboxypeptidase G2 (CPG2), and indole-3-acetic acid (IAA) activated by horseradish peroxidase (HRP) have no clinically established chemotherapeutic counterpart.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_provenance.
- NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_assertion evidence source_evidence_literature NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_provenance.
- NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_assertion SIO_000772 14529410 NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_provenance.
- NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_assertion wasDerivedFrom befree-20140225 NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_provenance.
- NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_assertion wasGeneratedBy ECO_0000203 NP830170.RAAUMtP4uEMaJhNC4fahgHXpz5_cMhJbgXciJCZF-V950130_provenance.